188 institutions reported holding $1.47B of MOOLAKE IMMUNOTHERAPEUTICS (MLTX) in SEC 13F filings for 2026-06-30. Largest institutional holders: BVF INC/IL ($311.5M), Deep Track Capital, LP ($136.3M), T. Rowe Price Investment Management, Inc. ($83.3M), D. E. Shaw & Co., Inc. ($65.5M), Cormorant Asset Management, LP ($62.4M). Source: SEC Form 13F.
来源:SEC 13F 申报文件 · 截至 2026-06-30